VIDAL Group Acquires Agence C.C.C., a Quality French Medical Events Agency ~ M3 Group Expands into Medical Events Sector for General Practitioners ~

[FY2024 Q2] Summary of Consolidated Financial Results

[FY2024 Q2] M3 Presentation Material

[Abridged] Announcement Concerning Results of Tender Offer for Shares of ELAN Corporation (Securities Code: 6099) and the Change in Subsidiary

M3’s Subsidiary CUC to Acquire Shares in Noah Konzer Co.,Ltd Which Operates Nursing Home in Sapporo to Make It The Consolidated Subsidiary

Capital and Business Alliance with ELAN Corporation

Notice Concerning Commencement of Tender Offer for Shares of ELAN Corporation (Securities Code: 6099), and Execution of Capital and Business Tie-up Agreement

[FY2024 Q1] Summary of Consolidated Financial Results

[FY2024 Q1] M3 Presentation Material

M3’s Subsidiary Cosmotec to Enter into Capital and Business Alliance with French Medical Device Startup, Sensome ~ Entry into the Neurosurgery Field by Acquisition of Exclusive Distribution Rights ~

White Jack Project Phase 7; M3 consolidates MinaCare, Which Provides Health Business Support Services ～ Accelerates Service Expansion for Health Insurance Associations ～

Matters Related to Controlling Shareholders, etc.

[FY2023 Q4] Summary of Consolidated Financial Results

[FY2023 Q4] M3 Presentation Material

Notice Concerning Differences between Actual Non-Consolidated Results for the Fiscal Year Ended March 31, 2024 and the Previous Fiscal Year Ended March 31, 2023

White Jack Project Phase 6; M3 consolidates Medcare, Which Provides Lifestyle Improvement Services ～ Expands Services for Health Insurance Associations to fulfill M3’s Mission ～

M3 consolidates Infrastructure for On Call Cooperation, Which Provides “Buddy On Call™”, House Call Agency Service during Nights and Holidays, for Medical Institutions ～Aiming to Build Infrastructure for Home Medical Care in Japan～

Announcement of Receipt of Dividends from Consolidated Subsidiaries

Notice Concerning Result of Tender Offer for Shares of Benefit One Inc. (Securities Code: 2412)

Notice of Amendment to Dividend Payout Forecast

Notice Regarding Change of Opinion of Benefit One Inc. for Tender Offer for Shares of Benefit One Inc. (Securities Code: 2412) and Extension of Tender Offer

Notice Regarding Change of Opinion of Benefit One Inc. for Tender Offer for Shares of Benefit One Inc. (Securities Code: 2412)

M3’s Subsidiary M3 Solutions to Enter into Capital Alliance with Atmark Inc Which Develops Automated Human Resources Matching System “arroba” ～Accelerating Staffing Services of Clinic DX Professionals～

[FY2023 Q3] Summary of Consolidated Financial Results

[FY2023 Q3] M3 Presentation Material

Notification of Extension of Tender Offer to Acquire Common Shares of Benefit One Inc.

M3’s Subsidiary CUC to Acquire Membership Interests in Albaron Podiatry Holdings, LLC Which Owns and Operates a Podiatry Service Platform under the Name of ‘Beyond Podiatry’

Notification of Extension of Tender Offer to Acquire Common Shares of Benefit One Inc.

M3 consolidates DBMCI to Advance Classroom-Based courses for Medical PG Preparation ~ Strengthening Education Service for Doctors and Medical Students in India ~

Notice Concerning Commencement of Tender Offer for Shares of Benefit One Inc. (Securities Code: 2412), and Execution of Capital and Business Tie-up Agreement

Capital and Business Alliance with Benefit One Inc.

[FY2023 Q2] Summary of Consolidated Financial Results

[FY2023 Q2] M3 Presentation Material

Notice of Application for the Tender Offer for the Shares of and Future Capital Alliance with Visionary Holdings Co., Ltd.

M3 Acquires DrSanté, a Fast-Growing Practice Management Software in France ~ Strengthening M3's Position as a Leading Provider in Ambulatory Care ~

M3 Acquires Messly, Leading Physician Recruiting Platform in the U.K. ~ Strengthening M3 Group's Ability to Address Staffing Shortages ~

M3 Acquires Frogwell, a Salesforce Consulting Service Provider in Japan ~ Accelerate the DX of Sales and Marketing Initiatives in the Healthcare Industry ~

[FY2023 Q1] Summary of Consolidated Financial Results

[FY2023 Q1] M3 Presentation Material

Final Agreement Concluded to Acquire Kantar’s Specialist Healthcare Research Businesses ~ Expansion of M3’s Global Healthcare Panel and Research Services ~

Acquisition of Kantar’s Two Healthcare Research Divisions -Supplemental Material -

Notice of Listing Approval of Consolidated Subsidiary (CUC Inc.)

[FY2022 Q4] M3 Presentation Material

[FY2022 Q4] Summary of Consolidated Financial Results

Notice Concerning Differences Between the Actual Consolidated Results for the Fiscal Year Ended March 31, 2023 versus the Respective Previous Fiscal Year

M3 Acquires Scribendi Inc. in Canada ~ Strengthen Research Paper Editing Platform and Accelerate its Globalization ~

M3 Acquires Med Planet in France ~ M3 Continues to Strengthen Capabilities and Reach with Latest French Acquisition ~

White Jack Project Phase 5: Merge of Happiness-i and Rinkai Medical Service ~"M3 Health Design" will play a central role in the White Jack Project ~

Notice of Amendment to Dividend Payout

Positive top-line results in Phase III studies of FSN-013

M3 Acquires Michael Allen Company in the U.S. ~ Strengthen Global Relationships with Pharmaceutical Companies ~

[FY2022 Q3] Summary of Consolidated Financial Results

[FY2022 Q3] M3 Presentation Material

M3 Acquires Remedium in the U.K. ~ New Entry into International Physician Recruiting Business ~

[FY2022 Q2] Summary of Consolidated Financial Results

[FY2022 Q2] M3 Presentation Material

White Jack Project Phase 4, 'EBHS Life' launched; New health indicator ~ Predicting relative life expectancy based on the results of health check-ups and lifestyle habits, promoting health management and improving the health of consumers ~

Full launch of M3 Cancer Prevention Program for Corporations ～3rd phase of the White Jack Project: Accelerating measures to combat a national disease affecting 1 out of 2 people～

M3 Acquires Rinkai Medical Service, Health Checkup Service Provider ~ Further initiative in the field of preventive medicine as Phase 2 of “White-Jack Project” ~

"RECELL® Autologous Cell Harvesting Device" Insurance Coverage Begins in Japan ~ Medical Device for Acute Burns and Donor Sites ~

[FY2022 Q1] M3 Presentation Material

M3 Launches “White-Jack Project,” an Initiative in the Field of Preventive Medicine ~ Acquiring Health Checkup Service Provider, Happiness-i, as Project Phase1 ~

[FY2022 Q1] Summary of Consolidated Financial Results

M3 acquires iDoctus, the leading HCP point-of-care mobile app operator in Spain, Mexico and rest of Latin America ~ Addition of widely used point-of-care app expands M3’s presence in key Spanish speaking regions ~

M3 Acquires pharma-insight GmbH in Germany ~ M3 Continues to Strengthen Capabilities and Panel with German Acquisition ~

M3 acquires U.S. Multi-Specialty Clinical Research Site ~ Expanding M3-Wake Research’s coverage to Florida ~

[FY2021 Q4] Summary of Consolidated Financial Results

Notice Concerning Differences Between Actual Consolidated and Non-consolidated Results for the Fiscal Year Ended March 31, 2022 versus the Respective Previous Fiscal Year

[FY2021 Q4] M3 Presentation Material

M3 Acquires Medical Accounting and EHR Business from Canon Medical Systems ~ Accelerating DX of Clinics along with M3 DigiKar, the No.1 Share Cloud EHR System ~

Launch of “Clinic Succession Platform” for Third-Party Accedence of Clinics ~ m3.com Platform to Support Sustainability of Medical Institutions Across Generations ~

Donation to Support Relief Activities in Ukraine ~ JPY 12,051,200 in Combined Donations from m3.com Members, Matched by M3 ~

M3 to Acquire Logic Inc. ~ Digital Transformation of Home Medical Care via SaaS for Nursing Care Facilities ~

"RECELL® Autologous Cell Harvesting Device" Gains Regulatory Approval in Japan ~ Medical Device for Acute Burns and Donor Sites ~

Notice of Amendment to Dividend Payout Forecast

M3 Acquires MirVracha LCC in Russia ~ Launching Full-Scale Development of Physician Platform Business in Russia ~

[FY2021 Q3] Summary of Consolidated Financial Results

[FY2021 Q3] M3 Presentation Material

M3 to Acquire 3H Holdings and Three Other Group Companies ~ Leading a next-generation clinical trial area leveraging largest patient recruitment panels ~

Launch of "Patient Centricity Promotion Center" ~ Patient-centric Drug Development by Mediscience Planning and QLife ~

French CME Provider ERON Santé Becomes Part of VIDAL Group ~ Becoming a Leading Provider of Online Continuing Medical Education ~

M3 Acquires Ekas Marketing in Australia ~ M3 Continues Expansion of Global Physician Coverage with Australian Acquisition ~

Notice of Selection of Prime Market in Tokyo Stock Exchange New Market Segments

Transfer of Shares of TamaBio to Quon Capital ~ TamaBio: Manufacturer of Artificial Biomembranes for Neurosurgery and Cardiac Surgery ~

“Medical Marketer” Service Tops Adoption by Over 100 Drugs ~ “Remote x Data x Personnel Pharma” Sales and Marketing Productivity Support Service ~

[FY2021 Q2] M3 Presentation Material

[FY2021 Q2] Summary of Consolidated Financial Results

No.1 Cloud Based EMR System “M3 DigiKar” Tops 3000 Clinic Adoptions ~ Medical Field DX Acceleration with “M3 DigiKar Smart” ~

[FY2021 Q1] M3 Presentation Material

[FY2021 Q1] Summary of Consolidated Financial Results

Recognition of Dilution Gains from Changes in Equity Interest Mainly Related to Medlive's Listing in Hong Kong

Capital Alliance with Epigno Co., Ltd ~ Accelerate DX of Talent Management for Medical Institutions ~

Pfizer On-boards Entire Sales Rep Force onto M3’s myMR-kun ~ Two-Way Digitalized Information Provision via Remote Detailing System ~

Announcement Regarding the Recognition of Gain Relating to Loss of Control Over Subsidiaries

M3 Acquires Stake in pA Medien GmbH to Expand Germany Business Platform ~ Investment in praktischArzt, the Leading Online Physician Recruitment Job Board in Germany ~

[FY2020 Q4] M3 Presentation Material

[FY2020 Q4] Summary of Consolidated Financial Results

Notice Concerning Differences Between Actual Consolidated and Non-consolidated Results for the Fiscal Year Ended March 31, 2021 versus the Respective Previous Fiscal Year

Launch of Cashless Payment System for Medical Facilities ~ Joint Effort Between ©Stripe and “M3 DigiKar,” the No.1 Cloud Based EHR System in Japan ~

Joint Development of Disease Awareness Service with Takeda ~ HAE Disease Awareness System on AskDoctors ~